TYR and Parkinson disease: The hydroxylation of the aromatic ring of TYR by tyrosinase (TYRO) in the presence of oxygen yields 3,4-dihydroxyphenyl-l-alanine (DOPA), the most commonly used treatment of Parkinson’s disease (Fig. 2) (Chávez-Béjar et al. 2012).